GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Autonomix Medical Inc (NAS:AMIX) » Definitions » Institutional Ownership

Autonomix Medical (Autonomix Medical) Institutional Ownership : 0.13% (As of Jun. 02, 2024)


View and export this data going back to 2024. Start your Free Trial

What is Autonomix Medical Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Autonomix Medical's institutional ownership is 0.13%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Autonomix Medical's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Autonomix Medical's Float Percentage Of Total Shares Outstanding is 39.66%.


Autonomix Medical Institutional Ownership Historical Data

The historical data trend for Autonomix Medical's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Autonomix Medical Institutional Ownership Chart

Autonomix Medical Historical Data

The historical data trend for Autonomix Medical can be seen below:

2024-03-31 2024-04-30
Institutional Ownership 0.13 0.13

Autonomix Medical Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Autonomix Medical (Autonomix Medical) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Website
Autonomix Medical Inc is a development stage medical device development company focused on advancing innovative technologies for sensing and treating disorders relating to the nervous system. Its first-in-class technology platform includes a catheter-based microchip-enabled array that can detect and differentiate neural signals with a high degree of sensitivity as demonstrated in animal studies.